Granulocyte-Colony Stimulating Factor Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Granulocyte-Colony Stimulating Factor (G-CSF) Market declined from $7.30 billion in 2019 to $6.91 billion in 2027 at a compound annual growth rate (CAGR) of 5%.

Granulocyte colony stimulating factor (G-CSF) is a glycoprotein that stimulates the bone marrow to produce and release stem cells and granulocytes into the bloodstream. G-CSF is produced by other tissues and its pharmacological analogues include lenograstim and filgrastim. G-CSF also stimulates proliferation, survival, differentiation and function of mature and neutrophil progenitors. G-CSF has a wide range of applications in hematology and oncology. Recombinant forms of G-CSF have been used in patients with certain cancers to reduce mortality and accelerate recovery from neutropenia after chemotherapy, providing a higher-intensity treatment regimen.

Market Segments

By Type

• Capsules
• Tablets
• Others

By Application

• Oncological Diseases
• Blood Disorders
• Growth Hormone Deficiencies
• Chronic and Autoimmune Disorders
• Others

Key Players

● Intas Pharmaceuticals Ltd
● Mylan
● Dr. Reddy’s Laboratories
● Novartis
● Pfizer Inc
● Merck KGaA
● Stada Arzneimittel AG
● Teva Pharmaceutical Industries Ltd

Scope of the Report

The research study analyzes the global Granulocyte-Colony Stimulating Factor industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Granulocyte-Colony Stimulating Factor Market Report

1. What was the Granulocyte-Colony Stimulating Factor Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Granulocyte-Colony Stimulating Factor Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Granulocyte-Colony Stimulating Factor Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.